| Serial Number | 97551508 |
| Word Mark | SELECT |
| Filing Date | Tuesday, August 16, 2022 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Tuesday, September 17, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, February 6, 2024 |
| Description of Mark | The mark consists of the wording "SeleCT" in which the initial letter "S" is rendered as a capital letter and the last two letters "CT" are rendered in capital letters, while the other letters are rendered in lowercase. |
| Goods and Services | Downloadable reports and documents in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; downloadable reports and documents featuring surgical and medical information in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; downloadable reports and documents featuring surgical information, medical information, and quantitative measures for use in connection with the evaluation and treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions; downloadable reports and documents featuring surgical information, medical information, and quantitative measures for use in connection with the visual readings of lung structures; downloadable reports and documents featuring surgical information, medical information, and quantitative measures for use in confirming the eligibility of patients and the identification of correct target lobes for endobronchial valve treatment; downloadable reports and documents featuring information about medical devices and medical procedures for use in connection with the evaluation and treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions and emphysema disease |
| Goods and Services | Printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing featuring surgical and medical information in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing featuring surgical information, medical information, and quantitative measures for use in connection with the evaluation, surgical treatment, and medical treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions and emphysema disease; printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing in the field of pulmonary medicine and quantitative computed tomography analysis; printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing in the field of pulmonary medicine featuring surgical information, medical information, and quantitative measures to support visual readings of lung structures; printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing in the field of pulmonary medicine featuring surgical information, medical information, and quantitative measures for use in confirming the eligibility of patients and the identification of correct target lobes for endobronchial valve treatment; printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing featuring information about medical devices and medical procedures for use in connection with the evaluation and treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions and emphysema disease |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Providing medical information regarding medical devices for the treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions, and emphysema disease; medical diagnostic testing, monitoring and reporting services in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; medical information services, namely, analysis and reporting services relating to the treatment of patients based on quantitative measurements of computed tomography scans in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; providing online medical record analysis services designed to provide patients and practitioners with customized data used to inform and recommend treatment options in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; providing a website featuring online medical information regarding medical devices and medical procedures for use in connection with the evaluation and treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions, and emphysema disease |
| Goods and Services | Providing temporary use of online non-downloadable software for quantitative computed tomography analysis in the field of pulmonary medicine and pulmonary disease, and generating reports corresponding to the foregoing; providing temporary use of online non-downloadable software featuring artificial intelligence for quantitative computed tomography analysis in the field of pulmonary medicine and pulmonary disease, and generating reports corresponding to the foregoing; providing temporary use of on-line non-downloadable software for analyzing patient data in the field of pulmonary medicine and the evaluation and treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions, and emphysema disease and generating reports corresponding to the foregoing; software as a service (SAAS) services featuring software for analyzing patient data in the field of pulmonary medicine and the evaluation and treatment of chronic obstructive pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions, and emphysema disease, and generating reports corresponding to the foregoing; software as a services (SAAS) services featuring software for quantitative data analysis of computed tomography scans and generating corresponding reports, all in the field of pulmonary medicine; software as a services (SAAS) services featuring software using artificial intelligence for quantitative data analysis of computed tomography scans and generating corresponding reports, all in the field of pulmonary medicine; software as a services (SAAS) services featuring temporary use of non-downloadable software for use in securely accessing and submitting medical information in the form of computed tomography scans, receiving quantitative data analysis of computed tomography scans, and generating corresponding reports, all in the field of pulmonary medicine; software as a services (SAAS) services featuring temporary use of non-downloadable software for use in securely accessing surgical information, medical information, and quantitative measures to support visual readings of lung structures, all in the field of pulmonary medicine; software as a services (SAAS) services featuring temporary use of non-downloadable software for use in securely accessing surgical information, medical information, and quantitative measures for use in confirming the eligibility of patients and the identification of correct target lobes for endobronchial valve treatment; software as a services (SAAS) services featuring temporary use of non-downloadable software for use in securely accessing information about medical devices and medical procedures for use in connection with the evaluation and treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions, and emphysema disease |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, June 13, 2023 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 016 - Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for stationery or household purposes; artists' materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); printers' type; printing blocks. |
| US Class Codes | 002, 005, 022, 023, 029, 037, 038, 050 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, June 13, 2023 |
| Primary Code | 016 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, June 13, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, June 13, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Olympus Corporation |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Tokyo 192-8507 JP |
| Party Name | Olympus Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Tokyo 192-8507 JP |
| Event Date | Event Description |
| Friday, August 19, 2022 | NEW APPLICATION ENTERED |
| Wednesday, September 7, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, June 2, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, June 13, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, June 13, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, June 13, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, June 13, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, June 13, 2023 | SUSPENSION LETTER WRITTEN |
| Tuesday, June 13, 2023 | LETTER OF SUSPENSION E-MAILED |
| Tuesday, June 13, 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Monday, December 11, 2023 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Thursday, December 21, 2023 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Thursday, December 21, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, December 21, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sunday, December 31, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, January 17, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, February 6, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, February 6, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 2, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, September 17, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, September 17, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, September 17, 2024 | SOU EXTENSION 1 FILED |
| Tuesday, September 17, 2024 | SOU EXTENSION 1 GRANTED |